Loading...
Market
Will Abbott Laboratories stock price recover to pre-verdict levels by December 31, 2024?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Stock market data from financial news websites and stock exchange records
Story
Missouri Jury Orders Abbott to Pay $495 Million in Infant Formula Case
Jul 27, 2024, 12:32 AM
Abbott Laboratories has been ordered to pay $495 million in damages after a Missouri jury found that its specialized formula for premature infants caused a serious gastrointestinal disease in an Illinois girl. The jury determined that Abbott failed to warn about the increased risk of developing the potentially fatal bowel disease. The verdict was reached on Friday, with the jury awarding compensatory damages to the affected family. The case has led to a significant financial impact on Abbott, as reflected in the company's stock performance.
View original story
Similar markets
Outperform • 25%
Underperform • 25%
Match performance • 25%
Significantly underperform • 25%
Yes • 50%
No • 50%
Stock price increases by more than 10% • 25%
Stock price increases by 5-10% • 25%
Stock price remains within +/- 5% • 25%
Stock price decreases by more than 5% • 25%